223 related articles for article (PubMed ID: 34624278)
1. SPARC knockdown attenuated TGF-β1-induced fibrotic effects through Smad2/3 pathways in human pterygium fibroblasts.
Fan J; Zhang X; Jiang Y; Chen L; Sheng M; Chen Y
Arch Biochem Biophys; 2021 Nov; 713():109049. PubMed ID: 34624278
[TBL] [Abstract][Full Text] [Related]
2. Bromfenac Inhibits TGF-β1-Induced Fibrotic Effects in Human Pterygium and Conjunctival Fibroblasts.
Chen K; Lai K; Zhang X; Qin Z; Fu Q; Luo C; Jin X; Hu J; Liu S; Yao K
Invest Ophthalmol Vis Sci; 2019 Mar; 60(4):1156-1164. PubMed ID: 30908581
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol inhibits TGF-β1-induced fibrotic effects in human pterygium fibroblasts.
Fan J; Wei S; Zhang X; Chen L; Zhang X; Jiang Y; Sheng M; Chen Y
Environ Health Prev Med; 2023; 28():59. PubMed ID: 37866886
[TBL] [Abstract][Full Text] [Related]
4. Critical Role of mTORC2-Akt Signaling in TGF-β1-Induced Myofibroblast Differentiation of Human Pterygium Fibroblasts.
Kim SW; Kim HI; Thapa B; Nuwormegbe S; Lee K
Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):82-92. PubMed ID: 30640966
[TBL] [Abstract][Full Text] [Related]
5. RhoA/ROCK Signaling Regulates TGF-β1-Induced Fibrotic Effects in Human Pterygium Fibroblasts through MRTF-A.
Xie J; Ning Q; Zhang H; Ni S; Ye J
Curr Eye Res; 2022 Feb; 47(2):196-205. PubMed ID: 34323621
[TBL] [Abstract][Full Text] [Related]
6. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of lysyl oxidase like 1 inhibits the proliferation and pro-fibrotic effects of transforming growth factor-β1-induced hypertrophic scar fibroblasts.
Ying M; Chen Y; Yuan B
Can J Physiol Pharmacol; 2021 Dec; 99(12):1272-1279. PubMed ID: 34283938
[TBL] [Abstract][Full Text] [Related]
9. A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway.
Nuwormegbe SA; Sohn JH; Kim SW
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5217-5226. PubMed ID: 29049722
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of FOXM1 inhibits activation of keloid fibroblasts and extracellular matrix production via inhibition of TGF-β1/Smad pathway.
Zhang Y; Cheng C; Wang S; Xu M; Zhang D; Zeng W
Life Sci; 2019 Sep; 232():116637. PubMed ID: 31288014
[TBL] [Abstract][Full Text] [Related]
11. Antifibrotic Effects of Sakuraso-Saponin in Primary Cultured Pterygium Fibroblasts in Comparison With Mitomycin C.
Lee H; Jeong H; Lee CM; Shin JA; Jang SW; Lee JH; Park SY; Kim JY; Tchah H
Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4784-4791. PubMed ID: 31743935
[TBL] [Abstract][Full Text] [Related]
12. Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo.
Ma SY; Park WS; Lee DS; Choi G; Yim MJ; Lee JM; Jung WK; Park SG; Seo SK; Park SJ; Han IY; Choi YH; Choi IW
Eur J Pharmacol; 2017 Sep; 811():199-207. PubMed ID: 28642129
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.
Li N; Feng F; Wu K; Zhang H; Zhang W; Wang W
Biomed Pharmacother; 2019 Nov; 119():109387. PubMed ID: 31487583
[TBL] [Abstract][Full Text] [Related]
14. Smad2 and Smad3 as mediators of the response of adventitial fibroblasts induced by transforming growth factor β1.
Ren M; Wang B; Zhang J; Liu P; Lv Y; Liu G; Jiang H; Liu F
Mol Med Rep; 2011; 4(3):561-7. PubMed ID: 21468608
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
[TBL] [Abstract][Full Text] [Related]
16. Extracellular SPARC cooperates with TGF-β signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts.
Carvalheiro T; Malvar Fernández B; Ottria A; Giovannone B; Marut W; Reedquist KA; Garcia S; Radstake TR
Rheumatology (Oxford); 2020 Sep; 59(9):2258-2263. PubMed ID: 31840182
[TBL] [Abstract][Full Text] [Related]
17. In vitro analyses of the anti-fibrotic effect of SPARC silencing in human Tenon's fibroblasts: comparisons with mitomycin C.
Seet LF; Su R; Toh LZ; Wong TT
J Cell Mol Med; 2012 Jun; 16(6):1245-59. PubMed ID: 21801304
[TBL] [Abstract][Full Text] [Related]
18. Specific Features of Fibrotic Lung Fibroblasts Highly Sensitive to Fibrotic Processes Mediated via TGF-β-ERK5 Interaction.
Kadoya K; Togo S; Tulafu M; Namba Y; Iwai M; Watanabe J; Okabe T; Jin J; Kodama Y; Kitamura H; Ogura T; Kitamura N; Ikeo K; Takeda T; Kondo N; Takahashi K
Cell Physiol Biochem; 2019; 52(4):822-837. PubMed ID: 30946557
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells.
Yang T; Chen M; Sun T
Cell Physiol Biochem; 2013; 31(6):863-74. PubMed ID: 23817018
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of
Wen J; Lin X; Gao W; Qu B; Zuo Y; Liu R; Yu M
J Ocul Pharmacol Ther; 2019; 35(6):331-340. PubMed ID: 31343394
[No Abstract] [Full Text] [Related]
[Next] [New Search]
